Home › Funds › SIGNAL TREE FINANCIAL PARTNERS LLC › ABT
SIGNAL TREE FINANCIAL PARTNERS LLC position in ABT
ABBOTT LABORATORIES · Health Care
SIGNAL TREE FINANCIAL PARTNERS LLC reported holding 2,611 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$258K, representing 0.17% of its reported portfolio and ranking #46 among its reported holdings. SIGNAL TREE FINANCIAL PARTNERS LLC has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How SIGNAL TREE FINANCIAL PARTNERS LLC's ABT position evolved
SIGNAL TREE FINANCIAL PARTNERS LLC first disclosed a stake in ABT in Q4 2024 at 2,715 shares (US$307K). The position peaked in Q2 2025 at 2,604 shares, worth US$354K. Across 8 filings, SIGNAL TREE FINANCIAL PARTNERS LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 2,611 shares valued at US$258K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 2.71K | $307.05K | New |
| Q1 2025 | 2.60K | $345.37K | Reduce |
| Q2 2025 | 2.60K | $354.12K | Hold |
| Q3 2025 | 2.60K | $347.50K | Hold |
| Q4 2025 | 2.60K | $326.21K | Hold |
| Q1 2026 | 2.59K | $265.98K | Hold |
| Q2 2026 | 2.60K | $236.16K | Hold |
| Q3 2026 | 2.61K | $258.01K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.65B), Charles Schwab Investment Management (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 57.16M sh · $5.65B · Q3 2026
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 44.98M sh · $4.45B · Q3 2026
- Capital International Investors 35.46M sh · $3.51B · Q3 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Franklin Resources 20.44M sh · $2.36B · Q3 2026
- Deutsche Bank AG 17.69M sh · $1.75B · Q3 2026
- MFS Investment Management 14.93M sh · $1.48B · Q3 2026
More on SIGNAL TREE FINANCIAL PARTNERS LLC
FAQ
How long has SIGNAL TREE FINANCIAL PARTNERS LLC held ABT?
SIGNAL TREE FINANCIAL PARTNERS LLC has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is SIGNAL TREE FINANCIAL PARTNERS LLC's current position in ABT?
As of Q3 2026, SIGNAL TREE FINANCIAL PARTNERS LLC holds 2.61K shares of ABT (ABBOTT LABORATORIES), valued at $258.01K, representing 0.17% of its reported portfolio and ranking #46.
Has SIGNAL TREE FINANCIAL PARTNERS LLC been buying or selling ABT?
In the latest 13F filing (Q3 2026), SIGNAL TREE FINANCIAL PARTNERS LLC held unchanged its position in ABT. The position peaked in Q2 2025 at 2.60K shares.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.